Gyre Therapeutics (GYRE) Non-Current Debt (2010 - 2014)
Gyre Therapeutics (GYRE) recorded Non-Current Debt of $142,000 in Q1 2014, down 84.5% from $918,000 a year earlier and down 49.8% from the prior quarter.
Powered by 
Analysis
Gyre Therapeutics (GYRE) Non-Current Debt (2010 - 2014) Analysis & Trends
At the end of FY2013, Gyre Therapeutics reported Non-Current Debt of $283,000, down 75.1% from FY2012.
- Annual Non-Current Debt has a three-year compound annual growth rate of -40.6% (FY2010 to FY2013).
- Across earlier years, Non-Current Debt came in at $1.14 million in FY2012 (-42.8%), $1.99 million in FY2011 (+47.2%) and $1.35 million in FY2010.
- The Q1 2014 figure is the lowest quarterly Non-Current Debt in data going back to Q4 2010.
- On a year-over-year basis, Non-Current Debt has declined for eight consecutive quarters, with an average decline of 55.6% over the last eight quarters.
- Peak year-over-year performance for Non-Current Debt in the last five years was growth of 47.2% in Q4 2011, against a decline of 84.5% in Q1 2014 at the low end.
- Per Business Quant, the preceding three quarters came in at $283,000 (Q4 2013), $478,000 (Q3 2013) and $699,000 (Q2 2013).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 37.34 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 62.48 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 51.08 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -108.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 51.86 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 23.83 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 60.50 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Gyre Therapeutics | 777.23 Mn | 579.94 Mn | 26.90 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2014 | 142,000.00 |
| Dec 31, 2013 | 283,000.00 |
| Sep 30, 2013 | 478,000.00 |
| Jun 30, 2013 | 699,000.00 |
| Mar 31, 2013 | 918,000.00 |
| Dec 31, 2012 | 1.14 Mn |
| Sep 30, 2012 | 1.35 Mn |
| Jun 30, 2012 | 1.56 Mn |
| Mar 31, 2012 | 1.78 Mn |
| Dec 31, 2011 | 1.99 Mn |
| Sep 30, 2011 | 2.20 Mn |
| Jun 30, 2011 | 2.44 Mn |
| Dec 31, 2010 | 1.35 Mn |
API Access
Gyre Therapeutics Non-Current Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-debt&ticker=GYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-debt", "ticker": "GYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-debt&ticker=GYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();